Published in Cell Metab on August 27, 2015
Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia. Mol Metab (2016) 1.42
Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 1.31
Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep (2015) 1.18
Microbiota-induced obesity requires farnesoid X receptor. Gut (2016) 0.96
The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol (2016) 0.93
Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol (2015) 0.91
Role of gut microbiota in atherosclerosis. Nat Rev Cardiol (2016) 0.90
Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol (2016) 0.88
The role of fatty acids in insulin resistance. Lipids Health Dis (2015) 0.88
Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res (2016) 0.87
Immunological contributions to adipose tissue homeostasis. Semin Immunol (2015) 0.86
Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res (2016) 0.84
Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med (2016) 0.83
Synbiotic approaches to human health and well-being. Microb Biotechnol (2017) 0.81
Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J Mol Med (Berl) (2016) 0.80
Dysbiosis and the immune system. Nat Rev Immunol (2017) 0.79
Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci (2016) 0.79
Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health (2016) 0.79
Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? Gut Microbes (2016) 0.79
Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet. Am J Physiol Gastrointest Liver Physiol (2016) 0.79
Altered Microbiota Contributes to Reduced Diet-Induced Obesity upon Cold Exposure. Cell Metab (2016) 0.78
Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78
Linking Dietary Patterns with Gut Microbial Composition and Function. Gut Microbes (2016) 0.77
Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol (2016) 0.77
Alterations in Gut Microbiota and Immunity by Dietary Fat. Yonsei Med J (2017) 0.76
Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76
The gut microbiota: a key regulator of metabolic diseases. BMB Rep (2016) 0.76
Western diets, gut dysbiosis, and metabolic diseases: Are they linked? Gut Microbes (2017) 0.76
Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci (2017) 0.76
Fish oil, lard and soybean oil differentially shape gut microbiota of middle-aged rats. Sci Rep (2017) 0.75
Influence of diet on the gut microbiome and implications for human health. J Transl Med (2017) 0.75
Impact of Ethanol and Saccharin on Fecal Microbiome in Pregnant and Non-Pregnant Mice. J Pregnancy Child Health (2015) 0.75
The role of dietary fat in obesity-induced insulin resistance. Am J Physiol Endocrinol Metab (2016) 0.75
Dietary cholesterol effects on adipose tissue inflammation. Curr Opin Lipidol (2016) 0.75
The Gut Microbiota: The Gateway to Improved Metabolism. Gastroenterol Clin North Am (2016) 0.75
Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol Metab (2016) 0.75
Non-alcoholic fatty liver and the gut microbiota. Mol Metab (2016) 0.75
Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology (2017) 0.75
Endotoxins are associated with visceral fat mass in type 1 diabetes. Sci Rep (2016) 0.75
Immunologic impact of the intestine in metabolic disease. J Clin Invest (2017) 0.75
Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet. Sci Rep (2017) 0.75
Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids. Front Immunol (2017) 0.75
Infections by human gastrointestinal helminths are associated with changes in faecal microbiota diversity and composition. PLoS One (2017) 0.75
Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice. Mol Nutr Food Res (2017) 0.75
Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin. Transl Res (2017) 0.75
Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass. ISME J (2017) 0.75
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment. Front Aging Neurosci (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
Diet rapidly and reproducibly alters the human gut microbiome. Nature (2013) 11.04
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Interactions between the microbiota and the immune system. Science (2012) 10.45
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell (2010) 8.69
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr (2006) 6.60
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A (2004) 5.58
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem (2006) 5.57
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med (2004) 4.29
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut (2013) 3.07
Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut (2011) 2.67
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2009) 2.59
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J (2010) 2.19
Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17
Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr (2008) 2.15
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut (2011) 2.06
Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut (2012) 1.99
Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab (2013) 1.85
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res (2012) 1.79
The influence of diet on the gut microbiota. Pharmacol Res (2012) 1.74
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60
Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol (2007) 1.44
Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med (2010) 1.41
Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med (2010) 1.37
Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev (2009) 1.32
Should yoghurt cultures be considered probiotic? Br J Nutr (2005) 1.27
In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci U S A (2002) 1.27
TLR4 and Insulin Resistance. Gastroenterol Res Pract (2010) 1.27
Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol (2013) 1.25
Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) (2009) 1.24
Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS One (2010) 1.15
Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun (2014) 1.05
Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J Pharmacol Exp Ther (2008) 0.99
The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immun (2012) 0.86
The Gut Microbiota Modulates Energy Metabolism in the Hibernating Brown Bear Ursus arctos. Cell Rep (2016) 1.51
Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome. Cell Metab (2015) 1.25
Linking Microbiota to Human Diseases: A Systems Biology Perspective. Trends Endocrinol Metab (2015) 1.05
Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production. Mol Metab (2016) 0.76
Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment. Biomaterials (2020) 0.75